Found 23 results
Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.. Mol Pharm. 17(7):2599-2611.
.
2020. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC Natural Adjuvant against Aspergillosis.. Pharmaceutics. 11(9)
.
2019. Nose-to-Brain Delivery.. J Pharmacol Exp Ther. 370(3):593-601.
.
2019. Unusual Enthalpy Driven Self Assembly at Room Temperature with Chitosan Amphiphiles.. Pharm Nanotechnol. 7(1):57-71.
.
2019. Nanoparticulate peptide delivery exclusively to the brain produces tolerance free, analgesia.. Journal of Controlled Release. E-pub ahead of print
.
2017. Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate.. International Journal of Pharmaceutics. 514(1):121-132.
.
2016. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments.. Pharmaceutical Research. :1-15.
.
2016. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.. Journal of controlled release : official journal of the Controlled Release Society. 197:87-96.
.
2015. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.. Molecular pharmaceutics. 12(2):420-431.
.
2015. Chitosan amphiphiles provide new drug delivery opportunities. Polymer International.
.
2014. The Oral and Intranasal Delivery of Propofol Using Chitosan Amphiphile Nanoparticles. Pharmaceutical ….
.
2014. Physical Characterisation and Long‐Term Stability Studies on Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ)—A New Drug Delivery Polymer. Journal of Pharmaceutical Sciences.
.
2014. Strategies To Deliver Peptide Drugs to the Brain. Molecular pharmaceutics. 11(4):1081-1093.
.
2014. Nanofiber-based delivery of therapeutic peptides to the brain. ACS nano. 7(2):1016-1026.
.
2013. Polymer Hydrophobicity Has a Positive Effect on the Oral Absorption of Cyclosporine A from Poly(ethylenimine) Based Nanomedicines. Pharmaceutical Nanotechnology. 1:15-25.
.
2013. Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Molecular pharmaceutics. 9(6):1764-1774.
.
2012. Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Molecular pharmaceutics. 9(1):14-28.
.
2012. Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy. Journal of Biophotonics. 5(5-6):458-468.
.
2012. Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy. Journal of Raman Spectroscopy. 43(5):681-688.
.
2012. A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine 5-enkephalin, to the Brain. Molecular pharmaceutics. 9(6):1665-1680.
.
2012. In silico modelling of drug-polymer interactions for pharmaceutical formulations.. Journal of The Royal Society Interface. 7 Suppl 4:S423-33.
.
2010. Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude.. Biomacromolecules. 7(12):3452-3459.
.
2006. Quaternary ammonium palmitoyl glycol chitosan--a new polysoap for drug delivery.. International Journal of Pharmaceutics. 224(1-2):185-199.
.
2001.